Potentially inappropriate medications (PIMs) and anticholinergic levels in the elderly: A population based study in a French region

Archives of Gerontology and Geriatrics

Volumn 59, Issue 3, 2014, Pages 630-635

  Beuscart, Jean Baptiste ^a,b   Dupont, Corinne ^c   Defebvre, Marie Margueritte ^c   Puisieux, Francois ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

^c Observatoire Régional de la Santé Nord Pas de Calais   (France)

Author keywords

Cholinergic antagonists; Elderly; Inappropriate prescription; Pharmacoepidemiology

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; HYDROXYZINE;

AGED; ANTICHOLINERGIC DRUG SCALE; ANTICHOLINERGIC EFFECT; ARTICLE; FEMALE; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; NURSING HOME; POLYPHARMACY; POTENTIALLY INAPPROPRIATE MEDICATION; PRESCRIPTION; PREVALENCE; SCORING SYSTEM; CLINICAL PRACTICE; DRUG UTILIZATION; ELDERLY CARE; EPIDEMIOLOGY; HOSPITALIZATION; INAPPROPRIATE PRESCRIBING; PHARMACOEPIDEMIOLOGY; PHARMACY; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CHOLINERGIC ANTAGONISTS; COMMUNITY PHARMACY SERVICES; DRUG UTILIZATION; FEMALE; FRANCE; HEALTH SERVICES FOR THE AGED; HOSPITALIZATION; HUMANS; INAPPROPRIATE PRESCRIBING; MALE; NURSING HOMES; PHARMACIES; PHARMACOEPIDEMIOLOGY; PHYSICIAN'S PRACTICE PATTERNS; PREVALENCE;

EID: 84908671311     PISSN: 01674943     EISSN: 18726976     Source Type: Journal    
DOI: 10.1016/j.archger.2014.08.006     Document Type: Article

References (33)

1. Akazawa M., Imai H., Igarashi A., Tsutani K. Potentially inappropriate medication use in elderly Japanese patients. The American Journal of Geriatric Pharmacotherapy 2010, 8(2):146-160. 10.1016/j.amjopharm.2010.03.005.
2. Amann U., Schmedt N., Garbe E. Prescribing of potentially inappropriate medications for the elderly: An analysis based on the PRISCUS list. Deutsches Ärzteblatt International 2012, 109(5):69-75. 10.3238/arztebl.2012.0069.
3. Amieva H., Meillon C., Helmer C., Barberger-Gateau P., Dartigues J.F. Ginkgo biloba extract and long-term cognitive decline: A 20-year follow-up population-based study. PLOS ONE 2013, 8(1):e52755. 10.1371/journal.pone.0052755.
4. Ancelin M.L., Artero S., Portet F., Dupuy A.-M., Touchon J., Ritchie K. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: Longitudinal cohort study. British Medical Journal 2006, 332(7539):455-458. 10.1136/bmj.38740.439664.DE.
5. Beers M.H. Explicit criteria for determining potentially inappropriate medication use by the elderly. A update. Archives of Internal Medicine 1997, 157(14):1531-1536.
6. Bhattacharya R., Chatterjee S., Carnahan R.M., Aparasu R.R. Prevalence and predictors of anticholinergic agents in elderly outpatients with dementia. American Journal Geriatric Pharmacotherapy 2011, 9(6):436-441. 10.1016/j.amjopharm.2011.10.001.
7. Bongue B., Laroche M.L., Gutton S., Colvez A., Guéguen R., Moulin J.J., et al. Potentially inappropriate drug prescription in the elderly in France: A population-based study from the French National Insurance Healthcare system. European Journal of Clinical Pharmacology 2011, 67(12):1291-1299. 10.1007/s00228-011-1077-5.
8. Bostock C.V., Soiza R.L., Mangoni A.A. Associations between different measures of anticholinergic drug exposure and Barthel Index in older hospitalized patients. Therapeutic Advances in Drug Safety 2013, 4(6):235-245. 10.1177/2042098613500689.
9. Carnahan R.M., Lund B.C., Perry P.J., Pollock B.G., Gulp K.R. The anticholinergic drug scale as a measure of drug-related anticholinergic burden: Associations with serum anticholinergic activity. Journal of Clinical Pharmacology 2006, 46(12):1481-1486. 10.1177/0091270006292126.
10. Chaudhry K.N., Chavez P., Gasowski J., Grodzicki T., Messerli F.H. Hypertension in the elderly: Some practical considerations. Cleveland Clinic Journal of Medicine 2012, 79(10):694-704. 10.3949/ccjm.79a.12017.
11. Coulomb, A., & Baumelou, A. (s.d.). Situation de l'automédication en France et perspectives d'évolution. à l'adresse Consulté 13 novembre 2013. http://www.ladocumentationfrancaise.fr/var/storage/rapports-publics/074000030/0000.pdf.
12. Durán C.E., Azermai M., Stichele R.H.V. Systematic review of anticholinergic risk scales in older adults. European Journal of Clinical Pharmacology 2013, 69(7):1485-1496. 10.1007/s00228-013-1499-3.
13. Gallagher P., Barry P., O'Mahony D. Inappropriate prescribing in the elderly. Journal of Clinical Pharmacy and Therapeutics 2007, 32(2):113-121. 10.1111/j. 1365-2710.2007.00793.x.
14. Gellad W.F., Grenard J.L., Marcum Z.A. A systematic review of barriers to medication adherence in the elderly: Looking beyond cost and regimen complexity. The American Journal of Geriatric Pharmacotherapy 2011, 9(1):11-23. 10.1016/j.amjopharm.2011.02.004.
15. Guaraldo L., Cano F.G., Damasceno G.S., Rozenfeld S. Inappropriate medication use among the elderly: A systematic review of administrative databases. BMC Geriatrics 2011, 11(1):79. 10.1186/1471-2318-11-79.
16. Haider S.I., Johnell K., Thorslund M., Fastbom J. Trends in polypharmacy and potential drug-drug interactions across educational groups in elderly patients in Sweden for the period 1992-2002. International Journal of Clinical Pharmacology and Therapeutics 2007, 45(12):643-653.
17. Hamilton H.J., Gallagher P.F., O'Mahony D. Inappropriate prescribing and adverse drug events in older people. BMC Geriatrics 2009, 9(1):5. 10.1186/1471-2318-9-5.
18. Hovstadius B., Hovstadius K., Astrand B., Petersson G. Increasing polypharmacy - an individual-based study of the Swedish population 2005-2008. BMC Clinical Pharmacology 2010, 10:16. 10.1186/1472-6904-10-16.
19. Huang K.-H., Chan Y.-F., Shih H.-C., Lee C.-Y. Relationship between potentially inappropriate anticholinergic drugs (PIADs) and adverse outcomes among elderly patients in Taiwan. Journal of Food and Drug Analysis 2012, 20(4). 930-937, 985. 10.6227/jfda.2012200423.
20. Lampela P., Lavikainen P., Garcia-Horsman J.A., Bell J.S., Huupponen R., Hartikainen S. Anticholinergic drug use, serum anticholinergic activity, and adverse drug events among older people: A population-based study. Drugs and Aging 2013, 30(5):321-330. 10.1007/s40266-013-0063-2.
21. Landi F., Russo A., Liperoti R., Cesari M., Barillaro C., Pahor M., et al. Anticholinergic drugs and physical function among frail elderly population. Clinical Pharmacology and Therapeutics 2007, 81(2):235-241. 10.1038/sj.clpt.6100035.
22. Laroche M.-L., Charmes J.-P., Merle L. Potentially inappropriate medications in the elderly: A French consensus panel list. European Journal of Clinical Pharmacology 2007, 63(8):725-731. 10.1007/s00228-007-0324-2.
23. Leikola S., Dimitrow M., Lyles A., Pitkälä K., Airaksinen M. Potentially inappropriate medication use among Finnish non-institutionalized people aged ≥65 years: A register-based, cross-sectional, national study. Drugs & Aging 2011, 28(3):227-236. 10.2165/11586890-000000000-00000.
24. Lima T.J., de V., Garbin C.A.S., Garbin A.J.Í., Sumida D.H., Saliba O. Potentially inappropriate medications used by the elderly: Prevalence and risk factors in Brazilian care homes. BMC Geriatrics 2013, 13(1):52. 10.1186/1471-2318-13-52.
25. Lowry E., Woodman R.J., Soiza R.L., Mangoni A.A. Clinical and demographic factors associated with antimuscarinic medication use in older hospitalized patients. Hospital Practice 2011, 39(1):30-36. 10.3810/hp.2011.02.371.
26. Maio V., Yuen E.J., Novielli K., Smith K.D., Louis D.Z. Potentially inappropriate medication prescribing for elderly outpatients in Emilia Romagna, Italy: A population-based cohort study. Drugs & Aging 2006, 23(11):915-924.
27. Marengoni A., Rizzuto D., Wang H.-X., Winblad B., Fratiglioni L. Patterns of chronic multimorbidity in the elderly population. Journal of the American Geriatrics Society 2009, 57(2):225-230. 10.1111/j. 1532-5415.2008.02109.x.
28. Matanović S.M., Vlahovic-Palcevski V. Potentially inappropriate medications in the elderly: A comprehensive protocol. European Journal of Clinical Pharmacology 2012, 68(8):1123-1138. 10.1007/s00228-012-1238-1.
29. Mintzer J., Burns A. Anticholinergic side-effects of drugs in elderly people. Journal of the Royal Society of Medicine 2000, 93(9):457-462.
30. Montastruc F., Laffont M., Bagheri H., Montastruc J.-L. Potentially inappropriate medications in the elderly in France: A study in community pharmacies in 2011-2012. European Journal of Clinical Pharmacology 2013, 69(3):741-742. 10.1007/s00228-012-1367-6.
31. Sergi G., De Rui M., Sarti S., Manzato E. Polypharmacy in the elderly: Can comprehensive geriatric assessment reduce inappropriate medication use?. Drugs & Aging 2011, 28(7):509-518. 10.2165/11592010-000000000-00000.
32. Vellas B., Coley N., Ousset P.-J., Berrut G., Dartigues J.-F., Dubois B. Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): A randomised placebo-controlled trial. Lancet Neurology 2012, 11(10):851-859. GuidAge Study Group. 10.1016/S1474-4422(12)70206-5.
33. Wawruch M., Macugova A., Kostkova L., Luha J., Dukat A., Murin J., et al. The use of medications with anticholinergic properties and risk factors for their use in hospitalised elderly patients. Pharmacoepidemiology and Drug Safety 2012, 21(2):170-176. 10.1002/pds.2169.